A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

A Mayer, Roslyn Francis, S.K. Sharma, B. Tolner, C.J. Springer, J. Martin, G.M. Boxer, J. Bell, A.J. Green, J.A. Hartley, C. Cruickshank, J. Wren, K.A. Chester, R.H.J. Begent

    Research output: Contribution to journalArticle

    59 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)6509-6516
    JournalClinical Cancer Research
    Volume12
    Issue number21
    DOIs
    Publication statusPublished - 2006

    Cite this

    Mayer, A ; Francis, Roslyn ; Sharma, S.K. ; Tolner, B. ; Springer, C.J. ; Martin, J. ; Boxer, G.M. ; Bell, J. ; Green, A.J. ; Hartley, J.A. ; Cruickshank, C. ; Wren, J. ; Chester, K.A. ; Begent, R.H.J. / A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 21. pp. 6509-6516.
    @article{5f8c514f854e4490adffbce82acbb4fe,
    title = "A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug",
    author = "A Mayer and Roslyn Francis and S.K. Sharma and B. Tolner and C.J. Springer and J. Martin and G.M. Boxer and J. Bell and A.J. Green and J.A. Hartley and C. Cruickshank and J. Wren and K.A. Chester and R.H.J. Begent",
    year = "2006",
    doi = "10.1158/1078-0432.CCR-06-0769",
    language = "English",
    volume = "12",
    pages = "6509--6516",
    journal = "Clinical Cancer Reserach",
    issn = "1078-0432",
    publisher = "American Association for Cancer Research Inc.",
    number = "21",

    }

    Mayer, A, Francis, R, Sharma, SK, Tolner, B, Springer, CJ, Martin, J, Boxer, GM, Bell, J, Green, AJ, Hartley, JA, Cruickshank, C, Wren, J, Chester, KA & Begent, RHJ 2006, 'A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug' Clinical Cancer Research, vol. 12, no. 21, pp. 6509-6516. https://doi.org/10.1158/1078-0432.CCR-06-0769

    A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. / Mayer, A; Francis, Roslyn; Sharma, S.K.; Tolner, B.; Springer, C.J.; Martin, J.; Boxer, G.M.; Bell, J.; Green, A.J.; Hartley, J.A.; Cruickshank, C.; Wren, J.; Chester, K.A.; Begent, R.H.J.

    In: Clinical Cancer Research, Vol. 12, No. 21, 2006, p. 6509-6516.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A Phase 1 Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody - Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug

    AU - Mayer, A

    AU - Francis, Roslyn

    AU - Sharma, S.K.

    AU - Tolner, B.

    AU - Springer, C.J.

    AU - Martin, J.

    AU - Boxer, G.M.

    AU - Bell, J.

    AU - Green, A.J.

    AU - Hartley, J.A.

    AU - Cruickshank, C.

    AU - Wren, J.

    AU - Chester, K.A.

    AU - Begent, R.H.J.

    PY - 2006

    Y1 - 2006

    U2 - 10.1158/1078-0432.CCR-06-0769

    DO - 10.1158/1078-0432.CCR-06-0769

    M3 - Article

    VL - 12

    SP - 6509

    EP - 6516

    JO - Clinical Cancer Reserach

    JF - Clinical Cancer Reserach

    SN - 1078-0432

    IS - 21

    ER -